31-Dec-10 | 31-Dec-09 | |||
---|---|---|---|---|
Revenue | ||||
Europe | 0.18 | 100% | 0.01 | 100% |
Total | 0.18 | 100% | 0.01 | 100% |
Profit Before Tax | ||||
Europe | (0.09) | n/a | (0.35) | 22% |
UK | 0.19 | n/a | (1.26) | 78% |
Unanalysed | 0.15 | n/a | 0.34 | n/a |
Total | 0.25 | n/a | (1.26) | 100% |
31-Dec-10 | 31-Dec-09 | |||
---|---|---|---|---|
Revenue | ||||
Drug development | 0.13 | 76% | n/a | n/a |
Self-test diagnostic kits | 0.04 | 24% | 0.01 | 100% |
Total | 0.18 | 100% | 0.01 | 100% |
Profit Before Tax | ||||
Drug development | 0.22 | n/a | (1.54) | 96% |
Self-test diagnostic kits | (0.12) | n/a | (0.06) | 4% |
Unanalysed | 0.15 | n/a | 0.34 | n/a |
Total | 0.25 | n/a | (1.26) | 100% |
You are here: research